Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7411 p124
29 July 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


No compelling evidence for herbal medicine use in COPD

There is no compelling evidence to support the use of herbal medicine for treating chronic obstructive pulmonary disease (COPD), according to a systematic review published in the European Respiratory Journal (2006;28:330).

Research fellow Ruoling Guo and colleagues from the Peninsula Medical School in Exeter examined data from 14 randomised controlled trials and identified several herbal remedies with the potential to improve pulmonary function, to relieve symptoms or to reduce exacerbation severity and frequency in COPD.

“Studies on herbal products containing Panax ginseng, Hedera helix, Salvia miltiorrhiza and some traditional Chinese herbal medicine decoctions generated encouraging results,” they say. However, the researchers warn that the studies are difficult to interpret, have many limitations and are generally of poor methodological quality. They suggest that, considering the popularity of herbal medicines, further, more rigorously designed, studies are needed.

“Target COPD” Information about new and emerging treatments for chronic obstructive pulmonary disease is contained in a report published this week by the Association of the British Pharmaceutical Industry. “Target COPD” can be found on the ABPI website (www.abpi.org.uk).

Back to Top


©The Pharmaceutical Journal